Ieq Capital »

Lexeo Therapeutics shares owned by Ieq Capital

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Ieq Capital from 13F filings

Historical chart of Ieq Capital investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Ieq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Ieq Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $223k 34k 6.64
2025-06-30 $48k 12k 4.02

More positions owned by Ieq Capital

Applovin Corp Com Cl A (APP)
Roblox Corp Cl A (RBLX)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Vanguard Index Fds Total Stk Mkt (VTI)
Crowdstrike Hldgs Cl A (CRWD)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Snowflake Com Shs (SNOW)

View all positions for Ieq Capital

Top funds holding Lexeo Therapeutics

Henderson Group
Frazier Life Sciences Management
Balyasny Asset Management
Affinity Asset Advisors
Citadel Advisors
Vestal Point Capital
Woodline Partners
Millennium Management
Vanguard Group
BlackRock
Point72 Asset Management
ADAR1 Capital Management
Blackstone Group
D1 Capital Partners
683 Capital Management

View all funds holding Lexeo Therapeutics